ESEuropeanSwitch
MO

Morphosys

MorphoSys is a German biopharmaceutical company developing antibody-based treatments for cancer and autoimmune diseases. It was acquired by Novartis in 2024.

Germany Founded 1992 Pay-as-you-go
🏢
Is this your company? Claim this listing to update your profile and add your logo. Free to claim — Enhanced Profile from £500 / €575 per year. See an example →

About Morphosys

MorphoSys is a German biopharmaceutical company developing antibody-based treatments for cancer and autoimmune diseases. It was acquired by Novartis in 2024.

Provider Details

HQ Germany
HQ City Munich
Founded 1992
Pricing Pay-as-you-go
Data Hosting Munich

Classifications